Price T Rowe Associates Inc Agios Pharmaceuticals, Inc. Put Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.2MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$265 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$257 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$228 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$182 Million2.8% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.2MShares$103 Million0.03% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.57B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...